CoChat

Long-Term Treatment with Antidepressant Drugs: The Spectacular Achievements of Propaganda

Fava, Giovanni A. · 2002 · Psychotherapy and Psychosomatics
Cited by 66

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

In the medical field, the term ‘propaganda’ generally refers to open and direct pharmaceutical operations (e.g. advertisements, talks by sales representatives and presents). It also has, however, a more subtle and pervasive connotation, related to media control. Noam Chomsky has been instrumental in disclosing such a link. He dates the first modern example of media control from the occasion when Woodrow Wilson was elected President of the United States in 1916, right in the middle of World War I:‘The population was extremely pacifistic and saw no reason to become involved in a European war. The Wilson administration was actually committed to war and had to do something about it. They established a government propaganda commission, called the Creel Commission, which succeeded, within six months, in turning a pacifist population into a hysterical, war-mongering population which wanted to destroy everything German, tear the German limb to limb, go to war and save the world’ [1], p. 7].Chomsky [1]analyzed the mechanisms whereby propaganda may unfold its potential: filtering information (selective perception), engineering opinion, using the public relations industry and marginalizing dissident cultures.In his latest essay, Chomsky [2]describes how these mechanisms are operational in the world events following the September 11 tragedy (the Afghanistan war).In the past 2 decades, clinical medicine has witnessed the emergence of special interest groups [3]. Corporate interests have fused with academic medicine to create an unhealthy alliance that works against objective reporting of clinical research (selective perception), sets up meetings and symposia with the specific purpose of selling the participants to the sponsors (engineering opinions), gets its prodigal experts into leading roles in journals, medical associations and nonprofit research organizations (public relations industry) and provides the appropriate degree of rejection of outliers (marginalization of dissident cultures).Current trends in prescribing antidepressant drugs provide an excellent example of the risk which clinical medicine faces.The starting point of this discussion is an issue which became very apparent in the 1990s, i.e. the high rate of relapse following discontinuation of antidepressant drugs in unipolar depression [4]. On the basis of a few controlled trials, long-term use of antidepresssant drugs to avoid relapse was advocated and became a common clinical practice [5]. This led to both extension of the duration of antidepressant drug therapy to the longest possible time for treating the acute episode of depression and suggestion of an indefinite (lifelong) pharmacological prevention of depression. At about the same time, the effectiveness of antidepressant drugs in the short-term treatment of anxiety disorders and the chronicity of many forms of anxiety disturbances paved the way for justification of years of ongoing drug treatment [6].The availability of antidepressant drugs which are far more tolerable than traditional tricyclics has also led to an extension of their use to forms of depression which do not reach the severity threshold of major depressive disorders and can be subsumed under the rubrics of minor depression and demoralization, despite lack of evidence for their efficacy in these situations [7]. Leading journal articles, symposia and practice guidelines push clinicians toward prescribing antidepressant drugs more and more. This propaganda, with respect to which the taint of conflict of interests has been highlighted recently in a consumer magazine [8], makes the clinician who would retain a cautious and balanced attitude feel like the person whom Chomsky [1]depicts as sitting alone in front of the TV, thinking that he must be crazy or outdated for not buying what comes out of the tube.Selective attention to the pharmacological aspects of depression therapy induced by propaganda can make the clinician unaware of a number of research findings which are worthy of clinical interest. Propaganda makes sure that these issues are neglected, if not carefully avoided. They are summarized in the following sections.There is evidence that casts doubt on the ability of antidepressant drugs to favorably affect the course of depressive illness, despite their recognized ability to treat the depressive episode and to prevent relapse while the patient is taking the drug. Viguera et al. [9]analyzed 27 studies with variable lengths of antidepressant treatment which reported follow-up of drug discontinuation. The duration of drug treatment did not seem to affect the long-term prognosis once the drug was discontinued. Whether you treat a depressed patient for 3 months or 3 years, it does not matter when you stop the drug (it does matter, of course, whether patients are on drugs or placebo). Indeed, there was a nonsignificant trend which suggested that the longer the drug treatment, the higher the likelihood of relapse [9]. An observational

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000056279

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 66

Metadata

Authors
Fava, G. A.
Venue
Psychotherapy and Psychosomatics
Publisher
S. Karger AG
Published
2002
Volume
71
Issue
3
Pages
127-132
ISSN
  • 0033-3190 (ISSN-L)
  • 1423-0348
OpenAlex
W2016909112
Cited by
66
References
21
FWCI
5.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.